Yashica Sequelle
The Yashica Sequelle is a sub-miniature-style film camera produced by the Japanese maker Yashica. It sits among the company's specialist 35mm-era bodies aimed at compact, novelty-format use rather than mainstream SLR buyers.
Sales data for the Sequelle is very thin: a single UK auction hammer result from 2022 shows the model selling for £50, so today's value guide rests on that one wholesale data point rather than a robust range. At saleroom level the Sequelle is a low-volume curio, and what it sells for can swing significantly with cosmetic condition and the presence of original accessories.
Sales History
Prices shown are UK auction hammer results — the wholesale level achieved in the saleroom. Neither buyer’s nor seller’s commission is included. Dealer and retail asking prices are typically higher.
Prices updated: August 2024
| Date | Price | Source | |
|---|---|---|---|
| Aug 2024 | £188 | Flints Auctions | |
|
Auction: Cameras & Scientific Auction (Lot 106) Title: A Yashica Sequelle Half Frame Camera
Description:
grey, serial number 17166, body G, light meter responds, controls appear to operate, with f/2.8 2.8cm lens, optics F-G, not battery tested, with caps, |
|||
|
Loading...
|
|||
| Jun 2022 | £50 | Flints Auctions | |
|
Auction: The Collectors Sale (Lot 413) Title: A Yashica Sequelle 35mm Half Frame Viewfinder Camera
Description:
chrome, body G, shutter not working when batteries are inserted, optics G, some dust present, in makers box with grip, (Qty: 1) |
|||
|
Loading...
|
|||
Frequently asked questions
What is a Yashica Sequelle worth today?
Based on the only UK auction record available, a Yashica Sequelle sold for £50 at hammer in 2022; with just one data point, that figure is indicative rather than a firm market price.
How much does a Yashica Sequelle sell for at UK auction?
The single recorded hammer price is £50, so realistic expectations for a similar example sit around that level, subject to condition.
Is the Yashica Sequelle a common camera?
No. It appears rarely in UK salerooms, which is why price evidence is limited and individual results carry more weight than a median.